By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Abbott Laboratories 

Department 383 AP6D
One Hundred Abbott Park Road
Abbott Park  Illinois  60064-3500  U.S.A.
Phone: 847-937-6100 Fax: 847-937-1511



Celera Diagnostics  Long-term strategic alliance to develop, manufacture and market a broad range of in vitro molecular diagnostic products for disease detection, disease progression monitoring and therapy selection.

Genetronics, Inc.  On November 26, 1997, Genetronics announced a supply agreement with Abbott Laboratories allowing Genetronics to purchase the approved anti-cancer drug bleomycin for use with Genetronics MedPulser® drug delivery system in treatment of cancer.

Metabolex, Inc. 

Celera Corporation  Broad program to discover, develop and commercialize therapies for the treatment of cancer, including therapeutic antibodies and small molecules.

Rosetta Inpharmatics, Inc.  Investigation on molecular basis of hepatoxicity

Medarex, Inc. 


Company News
Abbott (ABT) Hosts Conference Call For Second-Quarter Earnings 6/22/2016 7:31:29 AM
Abbott (ABT) Announces Positive Results From Groundbreaking Study Of FreeStyle Libre System For People With Type 1 Diabetes 6/14/2016 11:45:23 AM
Abbott (ABT) Declares 370th Consecutive Quarterly Dividend 6/10/2016 10:20:26 AM
Diasend Collaborates With Abbott (ABT) To Simplify Diabetes Data Management 6/9/2016 9:22:00 AM
Abbott (ABT) Tries to Bail Out of $5.8 Billion Deal as Alere (ALR) Faces Bribery Probes, But it Won't Be Easy 6/2/2016 6:36:53 AM
Abbott (ABT) Warns on Topera Catheter Spline Fracture Risk 5/24/2016 7:50:58 AM
Abbott (ABT) Announces Positive Results From Pivotal Study Of Tecnis Symfony IOL For Cataract Surgery 5/9/2016 6:44:58 AM
Abbott (ABT) To Present At Deutsche Bank (DB) Health Care Conference 5/5/2016 7:14:24 AM
Alere (ALR) Obtains Requisite Lender Approval For Extension To File Form 10-K; Announces Certain Developments Relating To The Pending Merger Transaction With Abbott (ABT) 4/29/2016 8:42:30 AM
Abbott (ABT) Tries to Back Out of $5.8B Alere (ALR) Deal, But Alere Says It’s Still On 4/29/2016 7:38:52 AM